Pangea Biomed is a leading brand in the field of precision oncology, revolutionizing cancer care with their cutting-edge products and services. Their mission is to redefine cancer care by combining disruptive molecular biology technology with state-of-the-art bioinformatics and machine learning. At the core of Pangea Biomed's offerings is the ENLIGHT platform, a proprietary tumor intelligence platform.

By going beyond actionable genomic abnormalities, ENLIGHT provides a deeper understanding of how a tumor would respond to therapy. It examines the molecular context in which targeted therapies operate, considering expression abnormalities that are more common than actionable mutations. Through the ENLIGHT platform, Pangea Biomed uncovers functional genetic interactions and builds gene social networks that reveal tumor vulnerabilities.

Their comprehensive analysis includes measures of activity such as expression, epigenetics, proteomics, and more. This holistic approach uncovers clinically relevant insights that go beyond approaches solely based on genomic alterations. Pangea Biomed is trusted by and partners with some of the most advanced medical institutions and research labs.

Their dedication to precision oncology is evident in their innovative products, commitment to scientific publications, and continuous pursuit of cutting-edge advancements. Contact Pangea Biomed today to redefine cancer care and improve clinical outcomes